Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Int J Infect Dis ; 106: 213-220, 2021 May.
Article in English | MEDLINE | ID: mdl-33711517

ABSTRACT

OBJECTIVE: The clinical profile, management and outcome of infective endocarditis (IE) may be influenced by socioeconomic issues. METHODS: A nationwide prospective study evaluated IE during the era of deep economic crisis in Greece. Epidemiological data and factors associated with 60-day mortality were analyzed through descriptive statistics, logistic and Cox-regression models. RESULTS: Among 224 patients (male 72.3%, mean age 62.4 years), Staphylococcus aureus (n = 62; methicillin-resistant S. aureus (MRSA) 33.8%) predominated in the young without impact on mortality (p = 0.593), whilst Enterococci (n = 36) predominated in the elderly. Complications of IE were associated with mortality: heart failure [OR 2.415 (95% CI: 1.159-5.029), p = 0.019], stroke [OR 3.206 (95% CI: 1.190-8.632), p = 0.018] and acute kidney injury [OR 2.283 (95% CI: 1.085-4.805), p = 0.029]. A 60-day survival benefit was solely related to cardiac surgery for IE during hospitalization [HR 0.386 (95% CI: 0.165-0.903), p = 0.028] and compliance with antimicrobial treatment guidelines [HR 0.487 (95% CI: 0.259-0.916), p = 0.026]. Compared with a previous country cohort study, history of rheumatic fever and native valve predisposition had declined, whilst underlying renal disease and right-sided IE had increased (p < 0.0001); HIV infection had emerged (p = 0.002). No difference in rates of surgery and outcome was assessed. CONCLUSIONS: A country-wide survey of IE highlighted emergence of HIV, right-sided IE and predominance of MRSA in the youth during a severe socioeconomic crisis. Compliance with treatment guidelines promoted survival.


Subject(s)
Endocarditis/epidemiology , Adolescent , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Cohort Studies , Endocarditis/microbiology , Endocarditis/mortality , Endocarditis/virology , Greece/epidemiology , Humans , Male , Middle Aged , Prospective Studies
2.
BMJ Case Rep ; 13(12)2020 Dec 21.
Article in English | MEDLINE | ID: mdl-33370951

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is nowadays the most common liver disease worldwide. Autoimmune hepatitis (AIH) is a relatively rare disease of the liver characterised by female predominance, circulating autoantibodies, polyclonal hypergammaglobulinaemia, interface hepatitis on histology and favourable response to immunosuppression. The possibility of an additional AIH diagnosis in patients with NAFLD (NAFLD/AIH concurrence) or the presence of AIH alone instead of a supposed NAFLD diagnosis represents a challenge for clinicians. We report herein two adult patients (a 33-year-old woman and a 59-year-old man) with a previous NAFLD diagnosis who proved finally to suffer from AIH alone. These two representative cases indicate how difficult and complicated could be sometimes the diagnosis of patients with AIH highlighting the range of disease manifestations and severity while they also underline that although NAFLD is by far the most frequent chronic liver disease this could not be always the case.


Subject(s)
Antibodies, Antinuclear/blood , Hepatitis, Autoimmune/diagnosis , Metabolic Syndrome/complications , Non-alcoholic Fatty Liver Disease/diagnosis , Obesity, Morbid/complications , Adult , Antibodies, Antinuclear/immunology , Biopsy , Diagnosis, Differential , Diagnostic Errors , Elasticity Imaging Techniques , Female , Hepatitis, Autoimmune/drug therapy , Hepatitis, Autoimmune/immunology , Hepatitis, Autoimmune/pathology , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunosuppressive Agents/administration & dosage , Liver/diagnostic imaging , Liver/immunology , Liver/pathology , Liver Function Tests , Male , Metabolic Syndrome/immunology , Middle Aged , Mycophenolic Acid/administration & dosage , Non-alcoholic Fatty Liver Disease/etiology , Obesity, Morbid/immunology , Prednisolone/administration & dosage
3.
Eur J Gastroenterol Hepatol ; 32(12): 1545-1552, 2020 12.
Article in English | MEDLINE | ID: mdl-32118851

ABSTRACT

OBJECTIVE: Wilson disease is a rare genetic disorder of copper metabolism with a wide range of clinical presentations. The aim of this study is to describe the 30-year clinical experience in the management of Wilson disease patients followed at two Greek referral centers. METHODS: A retrospective chart review was performed to identify past and present Wilson disease patients diagnosed during the last 30 years. RESULTS: Sixty-three patients were included. The median age of diagnosis was 19 (3-59) years, while nine (14%) patients were older than 40 years old. Clinical presentation included asymptomatic liver disease (57.1%), neurological disease (20.6%), overt liver disease (12.7%), acute liver failure (6.3%) and other (3.2%). Kayser-Fleischer rings were detected in 27/62 with a higher frequency in neurologic patients (P < 0.001). Ceruloplasmin values were low in 55/63 with significantly lower values in patients with neurological disease (P = 0.048) and in cirrhotic patients (P = 0.017). Increased 24-hour urine copper was measured in 59/63 patients. D-penicillamine was administered in 56/63 patients (88.8%), followed by trientine (6/63, 9.5%), while one patient needed liver transplantation at baseline. At least one treatment switch was performed in 18 patients. By the end of follow-up, all non-cirrhotic patients (25/25) were stable, 3/23 (13%) cirrhotic developed decompensated liver disease, two developed HCC, three received a liver transplant and two died. Five out of 13 neurologic patients had persisting symptoms despite treatment. CONCLUSION: Wilson disease presents with a wide spectrum of clinical manifestations and should be investigated even in older patients, as early diagnosis, close follow-up and treatment monitoring usually provide favorable outcomes.


Subject(s)
Carcinoma, Hepatocellular , Hepatolenticular Degeneration , Liver Neoplasms , Adult , Aged , Greece/epidemiology , Hepatolenticular Degeneration/diagnosis , Hepatolenticular Degeneration/epidemiology , Hepatolenticular Degeneration/therapy , Humans , Middle Aged , Penicillamine/therapeutic use , Retrospective Studies , Young Adult
4.
BMJ Case Rep ; 12(3)2019 Mar 20.
Article in English | MEDLINE | ID: mdl-30898943

ABSTRACT

Glycogenic hepatopathy (GH) is a rare complication of poorly controlled type 1 diabetes mellitus (T1DM). We present a 19-year-old woman with T1DM and autoimmune thyroiditis who admitted to our department because of abrupt onset intermittent abdominal pain in the right upper quadrant accompanied by laboratory evidence of acute anicteric hepatitis. Physical examination revealed significant hepatomegaly but the common imagining studies were negative. Following exclusion of common causes of acute hepatitis and because of the presence of smooth muscle antibodies in a young female patient with already established two autoimmune diseases, a liver biopsy was performed in order to exclude the potential presence of autoimmune hepatitis. However, liver histology showed typical findings of GH. Intense treatment targeting strict glycemic control resulted in normalisation of liver biochemistry. This case underlines that GH should be considered as a rare cause of acute hepatitis in T1DM patients with poor glycemic control.


Subject(s)
Diabetes Mellitus, Type 1/complications , Glycogen/metabolism , Hepatomegaly/complications , Diabetes Mellitus, Type 1/drug therapy , Female , Humans , Hypoglycemic Agents/administration & dosage , Infusions, Subcutaneous , Insulin/administration & dosage , Insulin/analogs & derivatives , Liver Function Tests , Young Adult
5.
BMJ Case Rep ; 11(1)2018 Dec 09.
Article in English | MEDLINE | ID: mdl-30567221

ABSTRACT

Rifampicin has been widely used due to its broad antibacterial spectrum. Acute haemolysis is a rarely encountered complication of rifampicin. A 58-year-old woman was admitted to our department because of high-grade fever with rigors, accompanied by abdominal and lumbar pain and laboratory evidence of acute haemolysis. She had been treated for brucellosis initially with doxycycline and streptomycin. Due to subsequent appearance of myositis, ciprofloxacin and rifampicin were added for treatment of localised brucellosis. After intravenous administration of rifampicin, the patient deteriorated significantly. After exclusion of other causes of haemolysis, autoimmune haemolytic anaemia related to rifampicin was established by strongly positive direct Coombs test. Drug withdrawal in conjunction with intravenous immune globulin and prednisolone resulted in resolution of haemolysis and no relapse in the ensuing 1-year period. Our case highlights the importance of recognising commonly administrative drugs as cause of haemolytic anaemia, that can often be life threatening.


Subject(s)
Anemia, Hemolytic, Autoimmune/chemically induced , Anti-Bacterial Agents/adverse effects , Brucellosis/drug therapy , Immunoglobulins, Intravenous/therapeutic use , Prednisolone/therapeutic use , Rifampin/adverse effects , Abdominal Pain/etiology , Anemia, Hemolytic, Autoimmune/drug therapy , Anti-Bacterial Agents/administration & dosage , Chills , Female , Fever , Humans , Middle Aged , Rifampin/administration & dosage , Treatment Outcome
6.
Gut ; 67(8): 1517-1524, 2018 08.
Article in English | MEDLINE | ID: mdl-28779025

ABSTRACT

OBJECTIVE: Primary sclerosing cholangitis (PSC) is a genetically complex, inflammatory bile duct disease of largely unknown aetiology often leading to liver transplantation or death. Little is known about the genetic contribution to the severity and progression of PSC. The aim of this study is to identify genetic variants associated with PSC disease progression and development of complications. DESIGN: We collected standardised PSC subphenotypes in a large cohort of 3402 patients with PSC. After quality control, we combined 130 422 single nucleotide polymorphisms of all patients-obtained using the Illumina immunochip-with their disease subphenotypes. Using logistic regression and Cox proportional hazards models, we identified genetic variants associated with binary and time-to-event PSC subphenotypes. RESULTS: We identified genetic variant rs853974 to be associated with liver transplant-free survival (p=6.07×10-9). Kaplan-Meier survival analysis showed a 50.9% (95% CI 41.5% to 59.5%) transplant-free survival for homozygous AA allele carriers of rs853974 compared with 72.8% (95% CI 69.6% to 75.7%) for GG carriers at 10 years after PSC diagnosis. For the candidate gene in the region, RSPO3, we demonstrated expression in key liver-resident effector cells, such as human and murine cholangiocytes and human hepatic stellate cells. CONCLUSION: We present a large international PSC cohort, and report genetic loci associated with PSC disease progression. For liver transplant-free survival, we identified a genome-wide significant signal and demonstrated expression of the candidate gene RSPO3 in key liver-resident effector cells. This warrants further assessments of the role of this potential key PSC modifier gene.


Subject(s)
Cholangitis, Sclerosing/genetics , Cholangitis, Sclerosing/pathology , Polymorphism, Single Nucleotide/genetics , Thrombospondins/genetics , Adult , Cholangitis, Sclerosing/mortality , Cohort Studies , Disease Progression , Female , Humans , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Proportional Hazards Models
7.
BMJ Case Rep ; 20172017 Apr 21.
Article in English | MEDLINE | ID: mdl-28432171

ABSTRACT

Episodic angio-oedema with eosinophilia (EAE) or Gleich's syndrome is a rare condition characterised by recurrent episodes of oedema and eosinophilia, accompanied by urticaria, fever and weight gain. The presence of ascites has not been reported so far. We report a 21-year-old Caucasian woman who presented with marked ocular oedema and ascites. Laboratory evaluation revealed marked eosinophilia. During the last 3 months, three episodes of facial and neck oedema were reported, which resolved spontaneously over a period of 3-5 days. The diagnosis of EAE was established after exclusion of secondary causes (infections, allergic reactions, collagen diseases, neoplasms) and clonal disorders associated with marked eosinophilia. Low-dose steroids resulted in eosinophil decrease and complete resolution of symptoms, including ascites. This case highlights that ascites can be a very rare manifestation of EAE particularly if other more frequent causes of ascites have been excluded and the clinical and laboratory findings are supportive of EAE.


Subject(s)
Angioedema/diagnosis , Ascites/etiology , Eosinophilia/diagnosis , Angioedema/drug therapy , Eosinophilia/drug therapy , Female , Humans , Steroids/therapeutic use , Treatment Outcome , Young Adult
8.
Adv Ther ; 32(12): 1192-205, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26610384

ABSTRACT

INTRODUCTION: Daptomycin, a rapid concentration-dependent bactericidal antibiotic, is approved at a dose of 4 mg/kg/day for the treatment of complicated skin and soft tissue infections (cSSTI) and at a dose of 6 mg/kg/day for the treatment of Staphylococcus aureus right-sided infective endocarditis (RIE) and bacteremia associated with cSSTI and RIE. Studies have reported the successful use of high-dose daptomycin (>6 mg/kg/day) in patients with difficult-to-treat infections. The present analysis evaluated the effectiveness and safety of high doses (>6 mg/kg/day) of daptomycin for the treatment of different Gram-positive infections. METHODS: European Cubicin(®) Outcomes Registry and Experience (EU-CORE) is a non-interventional, multicenter, retrospective, patient registry designed to collect real-world data from patients treated with daptomycin between 2006 and 2012. Clinical outcomes were assessed at the end of daptomycin treatment for three dose groups: ≤6, >6 to <8, and ≥8 mg/kg/day. Safety was assessed for up to 30 days post-daptomycin treatment. RESULTS: Of the 6075 patients enrolled in EU-CORE, 4892 patients received daptomycin doses ≤6 mg/kg/day, while 1097 patients received high doses (>6 mg/kg/day). The primary infections with the largest proportion of patients treated with a high dose (>6 mg/kg/day) were osteomyelitis (37.1%), foreign body/prosthetic infection (31.6%), and endocarditis (27.6%). S. aureus was identified in 42.9% of patients with positive cultures treated with either ≤6 or >6 mg/kg/day. The overall clinical success rate was 82.0% (899/1097) with high doses (>6 mg/kg/day) and 80.3% (3928/4890) with doses ≤6 mg/kg/day. Numerically higher clinical success rate was observed for endocarditis and foreign body/prosthetic infection, as well as for coagulase-negative staphylococcal and enterococcal infections, with high-dose daptomycin treatment. There were no new or unexpected safety findings at doses >6 mg/kg/day. CONCLUSION: These results suggested that daptomycin at doses >6 mg/kg/day was effective and well tolerated. High-dose daptomycin is a potential therapeutic option in patients with difficult-to-treat Gram-positive infections. FUNDING: This study was funded by Novartis Pharma AG.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Daptomycin/therapeutic use , Gram-Positive Bacterial Infections/drug therapy , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Daptomycin/administration & dosage , Daptomycin/adverse effects , Dose-Response Relationship, Drug , Europe , Female , Humans , Male , Middle Aged , Registries , Retrospective Studies , Treatment Outcome
9.
PLoS One ; 10(4): e0122761, 2015.
Article in English | MEDLINE | ID: mdl-25835293

ABSTRACT

A large collection of Staphylococcus aureus including a. 745 clinically significant isolates that were consecutively recovered from human infections during 2012-2013, b. 19 methicillin-susceptible (MSSA), randomly selected between 2006-2011 from our Staphylococcal Collection, c. 16 human colonizing isolates, and d. 10 strains from colonized animals was investigated for the presence and the molecular characteristics of CC398. The study was conducted in Thessaly, a rural region in Greece. The differentiation of livestock-associated clade from the human clade was based on canSNPs combined with the presence of the φ3 bacteriophage and the tetM, scn, sak, and chp genes. Among the 745 isolates, two MRSA (0.8% of total MRSA) and thirteen MSSA (2.65% of total MSSA) were found to belong to CC398, while, between MSSA of our Staphylococcal Collection, one CC398, isolated in 2010, was detected. One human individual, without prior contact with animals, was found to be colonized by a MSSA CC398. No CC398 was identified among the 10 S. aureus isolated from animals. Based on the molecular markers, the 17 CC398 strains were equally placed in the livestock-associated and in the human clades. This is the first report for the dissemination of S. aureus CC398 among humans in Greece.


Subject(s)
Anti-Bacterial Agents/pharmacology , Genes, Bacterial , Methicillin/pharmacology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/genetics , Animals , Cattle , Drug Resistance, Multiple, Bacterial , Greece/epidemiology , Humans , Livestock/microbiology , Microbial Sensitivity Tests , Molecular Typing , Rural Population , Sheep , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology , Staphylococcus Phages/genetics , Staphylococcus Phages/isolation & purification , Staphylococcus aureus/classification , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/virology , Swine
10.
Nat Genet ; 45(6): 670-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23603763

ABSTRACT

Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation. We compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip. We identified 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly stronger association with PSC than with IBD, suggesting overlapping yet distinct genetic architectures for these two diseases. We incorporated association statistics from 7 diseases clinically occurring with PSC in the analysis and found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together with network analyses, these findings add to the genetic risk map of PSC and expand on the relationship between PSC and other immune-mediated diseases.


Subject(s)
Cholangitis, Sclerosing/genetics , Case-Control Studies , Cholangitis, Sclerosing/immunology , Gene Frequency , Genetic Loci/immunology , Genetic Pleiotropy , Genome-Wide Association Study , Genotyping Techniques , Humans , Linkage Disequilibrium , Oligonucleotide Array Sequence Analysis , Polymorphism, Single Nucleotide , Risk Factors
11.
Cardiol Res Pract ; 2011: 574230, 2011.
Article in English | MEDLINE | ID: mdl-21637719

ABSTRACT

Salmonella spp. is the cause of commonly encountered infections, with seasonal pattern of occurrence and worldwide distribution. Some of the clinical manifestations such as gastroenteritis and bacteremia are common, whereas others like mycotic aneurysms and osteomyelitis are infrequent especially in immunocompetent patients. Salmonella has been rarely described as a cause of myocarditis in the literature. We describe a case of an 18-year-old previously healthy male patient with myocarditis after Salmonella enteritidis infection. Clinical manifestations and diagnostic approach of this severe complication are discussed with a review of the literature.

12.
Cancer Invest ; 25(1): 55-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17364558

ABSTRACT

Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer that arises from intrahepatic bile ducts. Its etiopathogenesis has been considered to be independent of the presence of chronic viral hepatitis infections or cirrhosis. These factors, particularly the hepatitis C virus, have been reported to play a role in the development of cholangiocarcinoma in a few studies, with inconclusive results. We report 2 cases of ICC that presented with a background of hepatitis B virus (HBV) infection and discuss the possible pathophysiological relationships between ICC and HBV infection, with an emphasis on the x gene of HBV.


Subject(s)
Bile Duct Neoplasms/virology , Bile Ducts, Intrahepatic/virology , Cholangiocarcinoma/virology , Hepatitis B/complications , Bile Duct Neoplasms/pathology , Bile Duct Neoplasms/physiopathology , Bile Ducts, Intrahepatic/pathology , Cholangiocarcinoma/pathology , Cholangiocarcinoma/physiopathology , Hepatitis B/pathology , Hepatitis B/physiopathology , Humans , Hypertension/complications , Magnetic Resonance Imaging , Male , Middle Aged , Smoking , Tomography, X-Ray Computed
13.
Eur J Intern Med ; 18(1): 48-55, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17223043

ABSTRACT

BACKGROUND: Hepatitis C virus (HCV) appears to be endemic in most parts of the world, but there is considerable geographic variation. In order to assess the geographic distribution of HCV in Thessaly, in central Greece, we conducted a retrospective study in HCV-infected patients attending the Academic Liver Unit of Thessaly University from 1999 to 2003. We also investigated whether variation among regions could be attributed to differences in risk factors. METHODS: We evaluated the records of 309 HCV patients whose origin and/or residence was in Thessaly. To identify risk factors that were independently associated with the place of birth and/or residence, adjusted odds ratios (OR) were calculated by logistic regression analysis. We also studied the medical records of 150 HCV-negative patients from the same areas in order to evaluate whether there are differences in risk factors reported by HCV-positive and HCV-negative patients. RESULTS: We found three municipalities with a high HCV frequency. The use of non-disposable, multiple-use glass syringes for medical purposes in the past was the only potential risk factor more frequently identified in these areas than in other places (OR=2.3; p<0.05). This risk factor was significantly (p<0.001) associated with older age of the infected patients. CONCLUSIONS: This study shows that the spread of HCV in the three regions may have occurred several years ago as a result of the use of multiple-use glass syringes. Differences in prevalence rates among different age groups, as well as among different areas, indicate the need for extensive studies to determine HCV epidemiology and to develop appropriate prevention programs.

14.
J Gastrointestin Liver Dis ; 15(3): 213-9, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17013444

ABSTRACT

AIM: To evaluate the significance of induction with high doses of pegylated interferon -2b (Peg-IFNalpha-2b) and the predictability of sustained virologic response (SVR) in naïve patients with chronic hepatitis C. METHODS: 188 consecutive naïve patients with chronic hepatitis C were enrolled in a randomised controlled clinical trial. Patients were randomised to receive either Peg-IFN -2b 3.0 mcg/kg QW x 12 weeks followed by 1.5 mcg/kg QW x 36 weeks plus 800-1200 mg ribavirin (Arm A) or Peg-IFNalpha-2b 1.5 mcg/kg QW x 48 weeks plus 800-1200 mg ribavirin (Arm B). HCV-RNA was obtained at 0, 4, 8, 12, 16, 24, 48 and 72 weeks. Differences between schemes were evaluated by Kaplan-Meier curves. Predictability of SVR was assessed by two-way contingency table analysis and ROC curve analysis. RESULTS: From 176 patients, 75 had genotype 1, 15 genotype 2, 75 genotype 3 and 11 genotype 4. No statistical significance emerged in HCV-RNA positivity, side effects and withdrawals between schemes. Patients with genotype 1 achieved lower SVR (46.6%) in comparison to patients with genotypes 2/3 (94.1%, p < 0.001) and 4 (90.9%, p = 0.002). The most appropriate time for estimation of SVR for genotype 1 is week 8 (accuracy = 0.84, AUC = 0.90) while predictability increases with time in genotypes 2/3, reaching maximum accuracy = 0.93 and AUC = 0.76 at week 16. CONCLUSION: Induction with high doses of Peg-IFNalpha-2b does not preclude better outcome and rapid virologic response at 4 weeks of treatment sufficiently predicts SVR. These findings might be useful in an attempt to gain supportive evidence for decision making in difficult-to-treat patients.


Subject(s)
Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/mortality , Adult , Antiviral Agents , Drug Therapy, Combination , Female , Humans , Interferon alpha-2 , Interferon-alpha , Male , Polyethylene Glycols , Recombinant Proteins , Ribavirin , Survival Analysis
15.
J Clin Immunol ; 26(6): 495-505, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17001515

ABSTRACT

Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of alpha-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-alpha-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-alpha-actinin antibody was found in 21/50 (42%) of AIH-1 patients, compared with 52/401 (12.9%) of liver disease control patients, and with 6/200 (6%) of blood donors. Anti-filamentous and anti-alpha-actinin activities were found specifically together in 66% of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-alpha-actinin complex assay, the binding of anti-filamentous actin to alpha-actinin-binding domain on actin was demonstrated, as well as that of anti-alpha-actinin on the actin-binding domain of alpha-actinin. Thus, the frequent combination of anti-filamentous and anti-alpha-actinin antibodies seems to be the hallmark of activity in AIH-1.


Subject(s)
Actinin/immunology , Actins/immunology , Autoantibodies/blood , Hepatitis, Autoimmune/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cross Reactions , DNA, Single-Stranded/immunology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged
16.
Scand J Gastroenterol ; 41(5): 573-6, 2006 May.
Article in English | MEDLINE | ID: mdl-16638700

ABSTRACT

OBJECTIVE: In view of the possible implication of various environmental factors in the pathogenesis of primary biliary cirrhosis (PBC), the role of appendectomy in patients with PBC and other chronic liver diseases from Central Greece was investigated. MATERIAL AND METHODS: The medical files of 68 patients with PBC and gender- and age-matched controls with chronic hepatitis C virus (HCV) infection (n=65) and chronic hepatitis B virus (HBV) infection (n=67) were reviewed for the history and time of appendectomy. RESULTS: Nineteen of 68 (27.9%) PBC patients, 32 of 65 (49.2%) patients with chronic HCV infection and 22 of 67 (32.8%) patients with chronic HBV infection had a history of appendectomy. There was a significant higher frequency of appendectomy in patients with chronic hepatitis C (p = 0.012, chi(2) test) compared to patients with PBC. There were no significant differences in the clinical and histological characteristics of PBC patients with or without a history of appendectomy. CONCLUSION: In this case-control study we were unable to provide evidence of an association between primary biliary cirrhosis and the occurrence of appendectomy.


Subject(s)
Appendectomy/adverse effects , Liver Cirrhosis, Biliary/epidemiology , Aged , Female , Greece/epidemiology , Humans , Liver Cirrhosis, Biliary/pathology , Liver Diseases/epidemiology , Male , Middle Aged , Retrospective Studies
17.
World J Gastroenterol ; 12(2): 336-9, 2006 Jan 14.
Article in English | MEDLINE | ID: mdl-16482641

ABSTRACT

Hepatopulmonary syndrome (HPS) is defined as a clinical triad including liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations. We report a 61-year-old male presented with fatigue, long-lasting fever, loss of weight, signs of portal hypertension, hepatosplenomegaly, cholestasis and progressive dyspnoea over the last year. Clinical, laboratory and histological findings confirmed the diagnosis of granulomatous hepatitis. HPS due to hepatic granuloma-induced portal hypertension was proved to be the cause of severe hypoxemia of the patient as confirmed by contrast-enhanced echocardiography. Reversion of HPS after corticosteroid therapy was confirmed by a new contrast-enhanced echocardiography along with the normalization of cholestatic enzymes and improvement of the patient's conditions. This is the first case of complete reversion of HPS in a non-cirrhotic patient with hepatic granuloma, indicating that intrapulmonary shunt in liver diseases is a functional phenomenon and HPS can be developed even in miscellaneous liver involvement as in this case.


Subject(s)
Granuloma/drug therapy , Hepatitis/drug therapy , Hepatopulmonary Syndrome/drug therapy , Methylprednisolone/therapeutic use , Echocardiography , Granuloma/complications , Hepatitis/complications , Hepatopulmonary Syndrome/diagnostic imaging , Hepatopulmonary Syndrome/etiology , Humans , Male , Middle Aged
18.
Eur J Gastroenterol Hepatol ; 18(1): 31-5, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16357616

ABSTRACT

OBJECTIVES: Hepatic encephalopathy in patients with end-stage liver cirrhosis is associated with alterations in sleep patterns. Cirrhosis may also affect pulmonary function and it might be involved in the development of obstructive sleep apnoea syndrome (OSAS) in patients with ascites. We carried out a study to evaluate the presence of OSAS in cirrhotic patients without evidence of ascites (early stage cirrhosis). METHODS: We investigated 20 patients with Child A or B cirrhosis (19 and one, respectively) and 10 non-cirrhotic patients with chronic viral hepatitis (disease control group). All subjects were interviewed and underwent a thorough physical examination, a full polysomnographic study and a pulmonary function testing by spirometry. Serum samples were also obtained in order to determine the liver function tests. RESULTS: The presence of OSAS and inverted sleep patterns was similar in cirrhotic patients and disease controls. However, significant correlations were revealed between age and hypopnoeas per hour of sleep; age and the Apneas/Hypopneas Index (AHI); age and FEV1/FVC; gamma-glutamyl transpeptidase and FEV1/FVC; and total bilirubin and total sleep time. CONCLUSIONS: Early stage cirrhosis is not associated with sleep disorders and OSAS. However, total bilirubin levels might be a useful laboratory marker for early assessment of disturbance in sleep patterns and therefore of subclinical hepatic encephalopathy in Child A cirrhosis.


Subject(s)
Liver Cirrhosis/complications , Sleep Apnea, Obstructive/etiology , Adult , Age Factors , Aged , Bilirubin/blood , Female , Forced Expiratory Volume , Hepatitis, Viral, Human/complications , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/physiopathology , Male , Middle Aged , Pilot Projects , Polysomnography , Prospective Studies , Severity of Illness Index , Vital Capacity
19.
J Autoimmun ; 25(4): 283-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16242912

ABSTRACT

We have recently reported differences in the hematopoiesis between autoimmune hepatitis type 1 (AIH-1) and primary biliary cirrhosis (PBC). In view of the notion that cytokines are regulators of hematopoiesis, we investigated in our tertiary center the cytokine production in the bone marrow (BM) of the same consecutive cohort of patients (13 AIH-1, 13 PBC, 10 healthy and 7 patients with cirrhosis due to chronic hepatitis B). Interferon-gamma (IFN-gamma), interleukin-4 (IL-4), interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) were determined in the supernatants of long-term BM cultures by ELISAs. IL-4, TNF-alpha and TGF-beta were found significantly increased in the BM of PBC patients compared to AIH-1 and both control groups. AIH-1 patients had significantly higher BM IL-10 compared to PBC patients and higher IL-10, IL-4 and TNF-alpha compared to controls. BM IFN-gamma was significantly higher in PBC and AIH-1 patients compared to controls. In AIH-1 patients, IL-10 was positively correlated with CD34+, CD34+/CD38- and CD34+/CD38+ cell proportions. In conclusion, the BM cytokine microenvironment of PBC and AIH-1 patients differs significantly compared to that of healthy individuals and cirrhotic patients of non-autoimmune etiology. Differences were also found between patients with PBC and AH-1. The implication of BM in the pathogenesis of autoimmune liver diseases is possible and needs further investigation.


Subject(s)
Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Cytokines/biosynthesis , Hepatitis, Autoimmune/metabolism , Liver Cirrhosis, Biliary/metabolism , Adult , Aged , Bone Marrow Cells/pathology , Cells, Cultured , Female , Hepatitis, Autoimmune/immunology , Hepatitis, Autoimmune/pathology , Humans , Liver Cirrhosis, Biliary/immunology , Liver Cirrhosis, Biliary/pathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...